Evidence map›Paper›PMID 25818884›Full record

ArticleMolecular and cellular endocrinology2015

Knockout of the transcription factor Nrf2: Effects on testosterone production by aging mouse Leydig cells.

Haolin Chen, Shiying Jin, Jingjing Guo, Ponvijay Kombairaju, Shyam Biswal, Barry R Zirkin

Abstract read
In one paragraph

Article in Molecular and cellular endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Age-related testosterone decline: mechanisms and intervention strategies.Reproductive biology and endocrinology : RB&E · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Male reproductive ageing: a radical road to ruin.Human reproduction (Oxford, England) · 2023
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Testicular aging, male fertility and beyond.Frontiers in endocrinology · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Haolin ChenDepartment of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205; The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: hchen13@jhu.edu.
Shiying JinDepartment of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
Jingjing GuoThe Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Ponvijay KombairajuDepartment of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
Shyam BiswalDepartment of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
Barry R ZirkinDepartment of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.
Johns Hopkins University · USWenzhou Medical University · CN

Funding

Aging and Leydig Cell FunctionR37AG021092 · NIA · JOHNS HOPKINS UNIVERSITY · PI ZIRKIN, BARRY R · 2006 to 2015
$4.0M
AGING AND LEYDIG CELL FUNCTIONR01AG021092 · NIA · JOHNS HOPKINS UNIVERSITY · PI ZIRKIN, BARRY R · 2002 to 2019
$3.1M
Hypogonadism in Men: Is It Reversible?R21AG051259 · NIA · JOHNS HOPKINS UNIVERSITY · PI ZIRKIN, BARRY R · 2016 to 2017
$446k
NIA NIH HHS R01 AG021092NIA NIH HHS R21 AG051259NIA NIH HHS R37 AG021092NIA NIH HHS R37 AG21092
6 · The paper itself

Abstract

Aging in rodents and men is associated with reduced serum levels of testosterone and Leydig cell testosterone productions. To further investigate the mechanism by which Leydig cell testosterone production declines, the effect of knocking out Nrf2, a master regulator of phase 2 antioxidant genes, was examined. In wild-type mice, testosterone production and serum testosterone levels remained unchanged through middle age (8 months), but then were reduced significantly by old age (21-24 months). In contrast, serum testosterone levels and Leydig cell testosterone production were reduced significantly in the Nrf2-/- mice as early as middle age, and were reduced further in the aged mice. Reduced steroidogenesis in the knockout mice was associated with reduced antioxidant capacity, and increased expression of protein nitrotyrosine residues, a marker of ROS. These results support the hypothesis that, over time, increases in oxidative stress contribute to or cause the reduced testosterone production that characterizes Leydig cell aging.

Indexed as

AgingAnimalsCells, CulturedHumansLeydig CellsMaleMiceMice, KnockoutNF-E2-Related Factor 2Oxidative StressTestosteroneTyrosine3-nitrotyrosineNfe2l2 protein, mouseNF-E2-Related Factor 2TestosteroneTyrosineAgingLeydig cellsNrf2Oxidative stress

Identifiers

PMID25818884
PMCPMC4465452
OpenAlexW2007232450

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.